-
1 Comment
Halma plc is currently in a long term uptrend where the price is trading 14.8% above its 200 day moving average.
From a valuation standpoint, the stock is 56.0% cheaper than other stocks from the Industrials sector with a price to sales ratio of 6.9.
Halma plc's total revenue sank by 0.0% to $327M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $42M since the same quarter in the previous year.
Finally, its free cash flow grew by 51.8% to $63M since the same quarter in the previous year.
Based on the above factors, Halma plc gets an overall score of 3/5.
Industry | Conglomerates |
---|---|
ISIN | GB0004052071 |
Exchange | F |
CurrencyCode | EUR |
Sector | Industrials |
Target Price | None |
---|---|
Dividend Yield | 0.8% |
Market Cap | 12B |
PE Ratio | 35.11 |
Beta | 0.63 |
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for H11.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025